Signaling pathways
-
BA8236 cis-TadalafilSummary: cis-Tadalafil is an inhibitor. - BA8237 PDE5-IN-9Summary: PDE5-IN-9 is an inhibitor (11.2 μM) PDE5-IN-9 shows interaction with Gln817, Tyr612 and Ala767 amino acid residues.
- BA8238 PDE11-IN-1Summary: PDE11-IN-1 is an inhibitor.
- BA8239 CirsimarinSummary: Cirsimarin is an anti-lipid flavonoid.
- BA8241 BI-4916Summary: BI-4916 is a precursor of BI-4924.
- BA8242 BI-4924Summary: BI-4924 is a lipophilic
- BA8243 PKUMDL-WQ-2101Summary: PKUMDL-WQ-2101 is a non-NAD competitive variant of phosphoglycerate dehydrogenase inhibitor.
- BA8244 PHGDH-IN-3Summary: PHGDH-IN-3 is a phosphoglycerate dehydrogenase inhibitor with oral activity.
- BA8245 PKUMDL-WQ-2201Summary: PKUMDL-WQ-2201 is a non-NAD+ competitive mutation inhibitor (=35.7 μM).
- BA8247 DPTIPSummary: DPTIP is a potent, neutral sphingomyelinase (exosome inhibitor) that crosses the blood-brain barrier.